U.S. federal trademark · Serial No. 74643295 · Reg. No. Y
cancer therapy using anti-idiotype antibodies to illicit and immune response to the specific antigen; cancer therapy using genetically engineered idiotype antibodies to illicit an immune response to the specific cancer antigen
anti-idiotype antibodies, antibodies which exhibit the properties of TAA antigens to elicit and immune response to the specific antigen
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.